Since SPRINT, what blood pressure targets are you adopting?

• Poll created by Jordan Weinstein
• 5 years ago.
• 158 votes

*Assume a patient <80 years-old, at least intermediate CV risk, no diabetes

If tolvaptan for ADPKD was approved for use but not deemed to be cost-effective, would you still prescribe it to your patients?

• Poll created by Jordan Weinstein
• 6 years ago.
• 107 votes

Which patients with ADPKD would you treat with Tolvaptan (multiple options possible)?

• Poll created by Jordan Weinstein
• 7 years ago.
• 392 votes

Do you recommend anticoagulation with warfarin for stroke prevention in ESRD patients with non-valvular atrial fibrillation?

• Poll created by Jordan Weinstein
• 7 years ago.
• 148 votes

Which drug should be added to an ACE inhibitor or ARB when managing diabetic hypertension?

• Poll created by Jordan Weinstein
• 9 years ago.
• 618 votes

Would you use a subsequent entry biologic erythropoietin in place of an originator drug when treating anemia?

• Poll created by Jordan Weinstein
• 9 years ago.
• 182 votes

Is NGAL a useful biomarker in the diagnosis and management of AKI?

• Poll created by Jordan Weinstein
• 9 years ago.
• 202 votes

Name the new potassium binder!

• Poll created by Jordan Weinstein
• 8 years ago.
• 150 votes

What is the role of ezetimibe in CKD patients with hyperlipidemia?

• Poll created by Jordan Weinstein
• 9 years ago.
• 340 votes

Would you enroll your patients in a study randomizing them to cinacalcet in earlier stage CKD, even if it risked hyperphosphatemia?

• Poll created by Jordan Weinstein
• 9 years ago.
• 235 votes